Distek: Instruments for Pharmaceutical Testing and Laboratories
Distek, Inc. is a private company founded in 1976, specialed in the manufacture of laboratory instruments for pharmaceutical testing, with a particular focus on dissolution systems and benchtop bioreactors. The company offers a comprehensive range of products, including water bath and bathless dissolution systems, media preparation equipment, bathless disintegration systems, and dissolution autosamplers. In addition, Distek provides a series of single-use bioreactors, ideal for cell and microbial bioprocessing applications, ranging from small to large volumes to meet various laboratory needs.
Distek’s headquarters are located in North Brunswick Township, NJ, USA, and the company is continuously committed to product innovation to ensure reliability and quality. Distek is renowned for its dedication to innovation and product excellence, being ISO certified since 2002 and holding several patents for instruments and accessories. This commitment is reflected in the continuous evolution of its product offering, with recent additions such as the ezfill+ media preparation system and the Eclipse 5300 dissolution autosampler, which reduce the risk of errors and improve testing accuracy.
Furthermore, the company offers validation and qualification services, supporting its customers in complying with global regulations and standards, including those required by the FDA and USP. This is especially critical for pharmaceutical manufacturers who rely on the accuracy and compliance of laboratory instruments to ensure the safety and effectiveness of their products.
Choosing the operational lease of Distek’s equipment allows laboratories and biotechnology companies to access cutting-edge technologies without the need for a significant initial investment. This solution offers greater flexibility, helps maintain competitiveness in the rapidly evolving biotechnology sector, and promotes more streamlined financial management, with the added benefit of tax deductibility on leasing fees.